liquid biopsy

News

Grail multi-cancer test taps into Hims & Hers network

Grail has teamed up with telehealth company Hims & Hers to boost access to its recently filed Galleri blood test for cancer screening.

News

ESMO: Grail's data on cancer blood test firms up

Data from a new phase 3 trial of Grail's blood test for multiple cancers show improved efficacy and a lower rate of false alarms than a prior study.

News

Grail plans FDA filing for cancer blood test after new trial

Grail is eyeing FDA approval of its Galleri cancer screening blood test after a second positive phase 3 trial.

News

Illumina admits defeat in Grail quest, opting to divest

Illumina has said it will divest cancer detection company Grail, marking the end of a long-running antitrust dispute that has claimed the jobs of its former CEO and chair.

News

Illumina fined €432m for ignoring Grail merger objection

The European Commission has levied a substantial penalty on DNA sequencing giant Illumina for closing its takeover of cancer detection company Grail without EU regulatory

News

ASCO: Grail’s cancer blood test ‘promising’ in UK trial

Researchers in the UK say Grail’s blood test for more than 50 different types of cancer has shown promise in a trial involving thousands of people with suspected cancer sy

Grail multi-cancer test taps into Hims & Hers network

ESMO: Grail's data on cancer blood test firms up

Grail plans FDA filing for cancer blood test after new trial

Illumina admits defeat in Grail quest, opting to divest

Illumina fined €432m for ignoring Grail merger objection

ASCO: Grail’s cancer blood test ‘promising’ in UK trial

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

liquid biopsy

Editor's Picks